Back to search
Triple Vessel Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Triple Vessel Disease trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Triple Vessel Disease trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase II trial tests alternate doses and dosing schedules of belantamab mafodotin in treating patients with triple-class multiple myeloma that has come bac…
The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which ty…
A prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Tribranch Embedded Aortic Triple-branch Arch Stent Graft System manufactured by End…
High blood pressure during pregnancy poses significant risks to both the mother and baby. A combination of factors, including advancing maternal age, rising obe…
This is a phase 1 study to find the recommended dose and schedule of mezigdomide and talquetamab in relapsed and refractory multiple myeloma (RRMM), and to test…
This phase I/II trial evaluates the safety and feasibility of early, response-based dose reduction of linvoseltamab in the treatment of patients multiple myelom…
This study is comprised of a main study, an observational study, and optional survey studies. The main study is being done to see whether using Duffy null speci…
The purpose of this study if to evaluate the efficacy and safety of TCA108 on treatment of hypertension.